menu search

Jim cramer does his homework on fulgent genetics

Cramer circled back to Fulgent Genetics after an investor asked him about the stock last week....

November 16, 2022, 8:06 pm

Virusight and technogenetics to expand collaboration for global deployment of innovative spectral-based pathogens diagnosis

Following the COVID-19 development success, the parties have signed a Memorandum of Understanding for a joint effort to develop new immediate tests fo...

November 15, 2022, 3:46 pm

Here's why "trend" investors would love betting on eneti (neti)

eneti (NETI) could be a great choice for investors looking to make a profit from fundamentally strong s...

November 15, 2022, 10:32 am

Myriad genetics' (mygn) urosuite to improve tailored treatment

Myriad Genetics' (MYGN) latest launch is expected to aid clinicians with access to tools that can assis...

November 14, 2022, 9:47 am

Deadline alert: kessler topaz meltzer & check, llp announces deadline in fulgent genetics, inc. securities fraud class action lawsuit

Fulgent Genetics, Inc. Video RADNOR, Pa., Nov. 13, 2022 (GLOBE NEWSWIRE) — The law firm of Kessler To...

November 13, 2022, 3:43 pm

Sophia genetics sa (soph) q3 2022 earnings call transcript

Start Time: 08:30 January 1, 0000 9:27 AM ET SOPHiA GenetiCS SA (NASDAQ:SOPH ) Q3 2022 Earnings Confere...

November 12, 2022, 1:31 pm

Goodbody health turns focus to preventative diagnostics

Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) said its focus is now on preventative diagnostics as it looks to become a “leading aggregator” of inn...

November 11, 2022, 3:31 am

Beam therapeutics to participate in upcoming investor conferences

CAMBRIDGE, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision g...

November 9, 2022, 6:30 am

Sophia genetics reports financial results for the third quarter of fiscal 2022

Sustainable growth momentum evident despite foreign exchange headwinds BOSTON and LAUSANNE, Switzerland, Nov. 08, 2022 (GLOBE NEWSWIRE) — SOPHiA G...

November 8, 2022, 11:59 am

Sophia genetics sa (soph) reports q3 loss, tops revenue estimates

SOPHiA GenetiCS SA (SOPH) delivered earnings and revenue surprises of -5.88% and 0.04%, respectively, f...

November 8, 2022, 9:48 am

Fulgent genetics, inc. (flgt) q3 2022 earnings call transcript

Fulgent Genetics, Inc. (NASDAQ:FLGT ) Q3 2022 Results Conference Call November 7, 2022 4:30 PM ET Compa...

November 7, 2022, 8:41 pm

Fulgent genetics, inc. (flgt) beats q3 earnings and revenue estimates

Fulgent Genetics, Inc. (FLGT) delivered earnings and revenue surprises of 88.24% and 1.89%, respectivel...

November 7, 2022, 7:35 pm

Krystal biotech: a buy for growth potential

Children suffering dystrophic epidermolysis bullosa (DEB), a serious genetic disease, are affectionatel...

November 6, 2022, 1:40 am

Sophia genetics to participate in upcoming november investor conferences

BOSTON and LAUSANNE, Switzerland, Nov. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GenetiCS SA (Nasdaq: SOPH), ...

November 4, 2022, 6:49 am

Why shares of myriad genetics dropped 24% this week

The genetic-testing company announced an acquisition and lowered its guidance....

November 3, 2022, 9:51 pm

Wave life sciences to webcast conference call of third quarter 2022 financial results on november 10, 2022

CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage ge...

November 3, 2022, 8:30 am

Usmc: an in-between vehicle

USMC offers a peculiar concentrated mix of mega-cap growth and value names with a tilt towards those that are less prone to fr...

September 11, 2022, 7:30 am

Ultragenyx and mereo biopharma to present setrusumab data update at asbmr

NOVATO, Calif. and MOUNTAIN VIEW, Calif. and LONDON, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), (“Ultragenyx�...

September 9, 2022, 8:22 pm

Sarepta therapeutics to present at the morgan stanley 20th annual global healthcare conference

CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision g...

September 6, 2022, 8:45 am


Search within

Pages Search Results: